← Mechanisms of action
IGF1R
SINGLE PROTEINHomo sapiens
Preferred name: Insulin-like growth factor I receptor ChEMBL ↗
Linked proteins
Drugs acting on this target (54)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bionetide | Agonist | experimental | Peptide | IGF1R agonist |
| igf-methotrexate | Agonist | experimental | Recombinant protein | IGF1R agonist |
| insulin glulisine (Apidra) | Agonist | approved | Recombinant protein | IGF1R agonist |
| mecasermin (Increlex) | Agonist | approved | Recombinant protein | IGF1R agonist |
| na-931 | Agonist | experimental | Small molecule | IGF1R agonist |
| nbi-6024 | Agonist | experimental | Peptide | IGF1R agonist |
| proinsulin human | Agonist | experimental | Recombinant protein | IGF1R agonist |
| ave-1642 | Antagonist | experimental | mAb | IGF1R antagonist |
| cixutumumab | Antagonist | experimental | mAb | IGF1R antagonist |
| figitumumab | Antagonist | experimental | mAb | IGF1R antagonist |
| ganitumab | Antagonist | experimental | mAb | IGF1R antagonist |
| ibi311 | Antagonist | experimental | mAb | IGF1R |
| mk-0646 | Antagonist | experimental | mAb | IGF1R antagonist |
| robatumumab | Antagonist | experimental | mAb | IGF1R antagonist |
| teprotumumab (Tepezza) | Antagonist | approved | mAb | IGF1R antagonist |
| vrdn-001 | Antagonist | experimental | mAb | IGF1R |
| ZB001 | Antagonist | experimental | mAb | IGF1R |
| cpd-1028 | Immunity, passive | experimental | mAb | IGF1R immunity, passive |
| [111in]-fpi-1547 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| [225ac]-fpi-1434 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| aew-541 | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| ave-1642 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| biib-022 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| bms754807 | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| cixutumumab | Inhibitor | experimental | mAb | IGF1R inhibitor |
| figitumumab | Inhibitor | experimental | mAb | IGF1R inhibitor |
| ganitumab | Inhibitor | experimental | mAb | IGF1R inhibitor |
| kw-2450 | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| linsitinib | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| lonigutamab | Inhibitor | experimental | mAb | IGF1R inhibitor |
| masoprocol (actinex) | Inhibitor | approved | Small molecule | IGF1R inhibitor |
| mhb018a | Inhibitor | experimental | Recombinant protein | IGF1R inhibitor |
| mk-0646 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| mm-141 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| ntb003 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| picropodophyllin | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| pl-225b | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| robatumumab | Inhibitor | experimental | mAb | IGF1R inhibitor |
| vrdn-003 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| w0101 | Inhibitor | experimental | mAb | IGF1R inhibitor |
| xl228 | Inhibitor | experimental | Small molecule | IGF1R inhibitor |
| 68ga-nodaga-zigf-1r:4 | Radiodepletion | experimental | mAb | IGF1R radiodepletion |
| insulin 287 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| insulin 320 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| insulin 338 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| insulin degludec (tresiba) | Supplementation | approved | Recombinant protein | IGF1R supplementation |
| insulin detemir (Levemir) | Supplementation | approved | Recombinant protein | IGF1R supplementation |
| insulin glargine (toujeo) | Supplementation | approved | Recombinant protein | IGF1R supplementation |
| insulin icodec | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| insulin lispro (humalog) | Supplementation | approved | Recombinant protein | IGF1R supplementation |
| insulin tregopil | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| insulin-like growth factor-binding protein-3 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| mk-2640 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |
| nnc0268-0965 | Supplementation | experimental | Recombinant protein | IGF1R supplementation |